1,3-Bis((S)-1-phenylpropyl)-1H-imidazol-3-ium chloride, 97%, 1g

1-Propyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 250mg

NHS C3 azides, ≥95%, 5 mg, plastic packaging.

Bis[2-(4-azidosalicylamido)ethyl] Disulfide>97.0%(HPLC)10mg

Pent-2-enedioic acid, 97.0%, 5g

(2E)-3-(4-bromophenyl)-1-(2,4-dimethylphenyl)prop-2-en-1-one, 95.0%, 10g

N-tert-Butylacetamide, 98%, 100g

2-(Piperazin-1-yl)quinoline, 95.0%, 500mg

2-Chloropyridine-4-carbothioic acid amide, 95.0%, 25g

5-bromo-4-fluoro-1H-pyrazole, 97%, 1g

2-Bromo-5-formylthiazole, 98.0%, 5g

Methyl 1,5-dimethyl-1H-pyrrole-2-carboxylate, 97%, 100mg

N-(Piperidin-4-yl)pyrazin-2-amine dihydrochloride, 1g